| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2017-03-31 | Diamyd® | type 1 diabetes | 3 | Diamyd Medical (Sweden) | Autoimmune diseases - Metabolic diseases |
| 2017-03-31 | mepolizumab | hypereosinophilic syndrome | 3 | GSK (UK) | Inflammatory diseases - Rare diseases |
| 2017-03-31 | ARGX-113 | primary immune thrombocytopenia | 2 | Argen-X (Belgium - The Netherlands) | Autoimmune diseases - Hematological diseases |
| 2017-03-30 | poziotinib | non-small cell lung cancer with EGFR exon 20 insertion mutations | 2 | Spectrum Pharmaceuticals (USA - NV) | Cancer - Oncology |
| 2017-03-30 | TAK-003 (live-attenuated tetravalent dengue vaccine candidate) | dengue fever | 2 | Takeda Pharmaceutical (Japan) | Infectious diseases |
| 2017-03-30 | VXM01m | preclinical | Vaximm (Germany) | Cancer - Oncology | |
| 2017-03-30 | VXM04m | preclinical | Vaximm (Germany) | Cancer - Oncology | |
| 2017-03-30 | VXM06 | preclinical | Vaxxim (Germany) | Cancer - Oncology | |
| 2017-03-30 | ADCT-402 | preclinical | ADC Therapeutics (Switzerland) | Cancer - Oncology | |
| 2017-03-30 | ADCT-502. | preclinical | ADC Therapeutics (Switzerland) | Cancer - Oncology | |
| 2017-03-29 | DPX-Survivac with epacadostat (INCB24360) and low-dose cyclophosphamide | recurrent ovarian cancer | 1b | Immunovaccine Technologies (Canada) Incyte (USA - DE) | Cancer - Oncology |
| 2017-03-28 | CB 2679d/ISU304 | hemophilia B | 1-2 | Catalyst Biosciences (USA - CA) | Rare diseases - Genetic diseases - Hematological diseases |
| 2017-03-28 | VX-661 ( tezacaftor) in combination with ivacaftor | people with cystic fibrosis ages 12 and older who have certain mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene | 3 | Vertex Pharmaceuticals (USA - MA) | Rare diseases - Genetic diseases - Lung diseases |
| 2017-03-27 | NKTR-358 | 1 | Nektar Therapeutics (USA - CA) | Autoimmune diseases - Inflammatory diseases | |
| 2017-03-27 | NKTR-358 | 1 | Nektar Therapeutics (USA - CA) | Autoimmune diseases – Inflammatory diseases | |
| 2017-03-27 | combination of Diamyd® with relatively high doses of vitamin D and ibuprofen | type 1 diabetes | 2 | Diamyd Medical (Sweden) | Autoimmune diseases - Metabolical diseases |
| 2017-03-27 | remimazolam | procedural sedation in patients undergoing colonoscopy | 3 | Paion (Germany) | CNS diseases |
| 2017-03-27 | sarecycline | acne | 3 | Allergan (Ireland) Paratek Pharmaceuticals (USA - MA) | Dermatological diseases |
| 2017-03-25 | evenamide (NW-3509) | schizophrenia | 2 | Newron Pharmaceuticals (Italy) | CNS diseases - Mental diseases |
| 2017-03-23 | ADC-1013 | advanced solid tumors | 1 | Alligator Bioscience (Sweden) | Cancer - Oncology |
